Back
Corcept Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
49
CORT
Corcept Therapeutics
Last Price:
$67.53
Seasonality Move:
7.35%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.08 | Sell |
| 20-day SMA: | 71.91 | Buy |
| 50-day SMA: | 72.65 | Sell |
| 200-day SMA: | 60.62 | Buy |
| 8-day EMA: | 72.25 | Buy |
| 20-day EMA: | 72.4 | Sell |
| 50-day EMA: | 68.43 | Buy |
| 200-day EMA: | 37.22 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 49.67 | Sell |
| Chaikin Money Flow: | 196306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.77 - 74.59) | Buy |
| Bollinger Bands (100): | (60.46 - 77.66) | Buy |
Corcept Therapeutics Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 72.27 while CORT 8-day simple moving average is 73.08, which is a Sell signal.
-
The stock price of CORT is 72.27 while Corcept Therapeutics 20-day SMA is 71.91, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 72.65 while CORT share price is 72.27, making it a Sell technically.
-
CORT stock price is 72.27 and Corcept Therapeutics 200-day simple moving average is 60.62, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Sell
49
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a SellThe current Corcept Therapeutics [CORT] share price is $72.27. The Score for CORT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.2B
Price in USD:
72.27
Share Volume:
675.8K
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
29.42
Sell
49
Corcept Therapeutics (CORT)
is a Sell
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 72.27 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 72.27 while CORT 8-day exponential moving average is 72.25, which is a Buy signal.
-
The stock price of CORT is 72.27 while Corcept Therapeutics 20-day EMA is 72.40, which makes it a Sell.
-
Corcept Therapeutics 50-day exponential moving average is 68.43 while CORT share price is 72.27, making it a Buy technically.
-
CORT stock price is 72.27 and Corcept Therapeutics 200-day simple moving average is 37.22, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.17, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 49.67, which suggest Corcept Therapeutics is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics is (69.77 - 74.59), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (60.46 - 77.66), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.